SUMOylation proteins in breast cancer
Alaa T Alshareeda1, Ola H Negm, Andrew R Green
1Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK, mrxaa31@nottingham.ac.uk.
Small Ubiquitin-like Modifier (SUMO) proteins influence DNA damage response and are implicated in breast cancer (BC) aggressiveness. Their nuclear localization correlates with better BC prognosis and links to DNA repair proteins.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Small Ubiquitin-like Modifier (SUMO) proteins regulate key cellular processes, including DNA damage response (DDR).
- Dysregulated SUMOylation is linked to carcinogenesis through altered post-transcriptional modification of proteins.
- SUMO's role in aggressive breast cancer (BC), particularly BRCA1-mutated types, warrants investigation.
Purpose of the Study:
- To evaluate the clinical and biological significance of PIAS1, PIAS4, and UBC9 (SUMO proteins) in breast cancer.
- To investigate the association between SUMO protein expression, subcellular localization, and DNA damage response (DDR) pathways.
- To explore the correlation of SUMO proteins with established breast cancer prognostic markers and BRCA1 status.
Main Methods:
- Immunohistochemistry on tissue microarrays of primary invasive breast cancer (BC) specimens.
- Reverse phase protein microarray (RPPA) analysis of SUMO protein expression in cell lines.
- Assessment of PIAS1, PIAS4, and UBC9 expression and subcellular localization (nuclear vs. cytoplasmic).
Main Results:
- PIAS1 and UBC9 exhibited cytoplasmic and/or nuclear localization, while PIAS4 was exclusively nuclear.
- Positive nuclear/negative cytoplasmic SUMO expression correlated with favorable prognostic features (e.g., lower histologic grade) and better patient outcomes.
- Significant correlations were observed between SUMO protein expression and DDR-related proteins (BRCA1, Rad51, ATM, CHK1, DNA-PK, KU70/KU80).
Conclusions:
- SUMO proteins play a significant role in breast cancer biology.
- Both the expression level and subcellular localization of SUMO proteins are associated with breast cancer phenotype and prognosis.
- SUMOylation pathways may represent potential therapeutic targets in breast cancer, especially in BRCA1-deficient tumors.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....


